391 related articles for article (PubMed ID: 37201112)
21. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling.
Li Z; Zhang Y; Hong W; Wang B; Chen Y; Yang P; Zhou J; Fan J; Zeng Z; Du S
Gut Microbes; 2022; 14(1):2119055. PubMed ID: 36093568
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice.
Zhu Q; Xia P; Zhou X; Li X; Guo W; Zhu B; Zheng X; Wang B; Yang D; Wang J
Front Cell Infect Microbiol; 2019; 9():377. PubMed ID: 31750262
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma.
Behary J; Amorim N; Jiang XT; Raposo A; Gong L; McGovern E; Ibrahim R; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O'Sullivan J; Weltman M; McCaughan G; El-Omar E; Zekry A
Nat Commun; 2021 Jan; 12(1):187. PubMed ID: 33420074
[TBL] [Abstract][Full Text] [Related]
25. The Effects of Tangning Ziyabitusi on Gut Microbiota and T lymphocyte Subsets in Impaired Glucose Regulation Rats.
Zhao B; Nuli R; Jiao Y; Zhang B; Wang L; Guan Y
Front Biosci (Landmark Ed); 2022 Sep; 27(9):278. PubMed ID: 36224015
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Zhang M; Zhao H; Gao H
Viral Immunol; 2022 Apr; 35(3):212-222. PubMed ID: 35099297
[TBL] [Abstract][Full Text] [Related]
27. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
28. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.
Zhang W; Xu X; Cai L; Cai X
Sci Rep; 2023 May; 13(1):7797. PubMed ID: 37179446
[TBL] [Abstract][Full Text] [Related]
29. The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.
Lin Z; Mao D; Jin C; Wang J; Lai Y; Zhang Y; Zhou M; Ge Q; Zhang P; Sun Y; Xu K; Wang Y; Zhu H; Lai B; Wu H; Mu Q; Ouyang G; Sheng L
Front Immunol; 2023; 14():1105293. PubMed ID: 36891300
[TBL] [Abstract][Full Text] [Related]
30. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma.
Liu Q; Li F; Zhuang Y; Xu J; Wang J; Mao X; Zhang Y; Liu X
Gut Pathog; 2019; 11():1. PubMed ID: 30675188
[TBL] [Abstract][Full Text] [Related]
31. Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan.
Kaiyrlykyzy A; Kozhakhmetov S; Babenko D; Zholdasbekova G; Alzhanova D; Olzhayev F; Baibulatova A; Kushugulova AR; Askarova S
Sci Rep; 2022 Sep; 12(1):15115. PubMed ID: 36068280
[TBL] [Abstract][Full Text] [Related]
32. Relationship between gut microbiota dysbiosis and immune indicator in children with sepsis.
Lin X; Abdalla M; Yang J; Liu L; Fu Y; Zhang Y; Yang S; Yu H; Ge Y; Zhang S; Kang G; Dang W; Jiang Q; Wang Y; Gai Z
BMC Pediatr; 2023 Oct; 23(1):516. PubMed ID: 37845615
[TBL] [Abstract][Full Text] [Related]
33. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
34. Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures.
Liu Y; Kim ES; Guo H
J Med Virol; 2024 Feb; 96(2):e29485. PubMed ID: 38377167
[TBL] [Abstract][Full Text] [Related]
35. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.
Li YN; Kang NL; Jiang JJ; Zhu YY; Liu YR; Zeng DW; Wang F
World J Gastroenterol; 2022 Sep; 28(35):5188-5202. PubMed ID: 36188719
[TBL] [Abstract][Full Text] [Related]
36. Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8
Rong Y; Dong Z; Hong Z; Jin Y; Zhang W; Zhang B; Mao W; Kong H; Wang C; Yang B; Gao X; Song Z; Green SE; Song HK; Wang H; Lu Y
Exp Cell Res; 2017 Sep; 358(2):352-359. PubMed ID: 28694023
[TBL] [Abstract][Full Text] [Related]
37. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model.
Bu Y; Zhao K; Xu Z; Zheng Y; Hua R; Wu C; Zhu C; Xia Y; Cheng X
Virol Sin; 2023 Jun; 38(3):335-343. PubMed ID: 37141990
[TBL] [Abstract][Full Text] [Related]
39. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
[TBL] [Abstract][Full Text] [Related]
40. Depletion of Gut Microbiota Impairs Gut Barrier Function and Antiviral Immune Defense in the Liver.
Guo W; Zhou X; Li X; Zhu Q; Peng J; Zhu B; Zheng X; Lu Y; Yang D; Wang B; Wang J
Front Immunol; 2021; 12():636803. PubMed ID: 33841420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
